381 publications

Name Date Type Actions

2023 HALF-YEAR RESULTS

Sales: €256m (-5.4% as reported)
Essentials products sales: €151m (59% of Group sales)
Net income - Group share: €32m (12.6% of sales)
EBITDA*: €54m (20.9% of sales)
Cash-flow generation: €31m

 		07/09/2023 Public releases

Monthly information regarding the total number of voting rights - July 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		22/08/2023 Voting rights

Q1 2023 Sales: €145M

Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates.

 		20/04/2023 Public releases

Availability of the 2022 universal registration document

On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

 		13/04/2023 Public releases

Monthly information regarding the total number of voting rights - March 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		05/04/2023 Voting rights

Monthly information regarding the total number of voting rights - April 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		05/04/2023 Voting rights

Monthly information regarding the total number of voting rights - May 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		05/04/2023 Voting rights

Monthly information regarding the total number of voting rights - June 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		05/04/2023 Voting rights

2022 ANNUAL RESULTS

Annual sales: €540m (up 3.6% as reported)
Essentials sales: €304m (up 4.5% as reported)
EBIT before depreciation of acquired assets: €99m (18.3% of sales)
Net income - Group share: €48m (8.9% of sales)
EBITDA: €118m (21.9% of sales)
Free cash-flow: €63m

 		23/03/2023 Public releases

Monthly information regarding the total number of voting rights - February 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the « Reglement Général de L’Autorité des Marchés Financiers »

 		06/03/2023 Voting rights